COMMUNIQUÉS West-GlobeNewswire

Photocure ASA: Mandatory notification of trade
03/09/2018
Oslo, Norway, 3 September 2018: Photocure ASA (OSE: PHO), announces today that it has repurchased 1,121 own shares at NOK 0 per share in relation to the long-term incentive programme described in the stock exchange [...]
Nexstim Plc reports results of the supplementary Phase III E-FIT trial
03/09/2018
Company announcement, Helsinki, 3 September 2018 at 9:00AM Nexstim Plc reports results of the supplementary Phase III E-FIT trial Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), the targeted [...]
Shire plc: Rule 2.9 Announcement
03/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 September 2018 [...]
FIT Biotech Oy: Invitation to FIT Biotech Oy's briefing related to half-year financial report on September 6th 2018, at 10.00 AM.
03/09/2018
FIT Biotech Oy Press Release September 3 rd 2018, 08.45 EET Invitation to FIT Biotech Oy's briefing related to half-year financial report on September 6 th 2018, at 10.00 AM. FIT Biotech will publish its half-year [...]
Sensorion Announces Three Poster Presentations At The 55th Inner Ear Biology Workshop
03/09/2018
MONTPELLIER, France, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN ), a biotech company specializing in the treatment of inner ear diseases, will present three posters at the 55 th Inner Ear Biology [...]
Tecan successfully completes the acquisition of NuGEN Technologies
03/09/2018
Männedorf, Switzerland, September 3, 2018 - The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the acquisition of NuGEN Technologies, Inc. (NuGEN) on August 31, 2018. On August [...]
Sanofi: Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
03/09/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP) First therapeutic approved for the treatment of [...]
Sanofi : Cablivi(TM) (caplacizumab) approuvé en Europe dans le traitement du purpura thrombotique thrombocytopénique (PTT) acquis de l'adulte
03/09/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Cablivi(TM) (caplacizumab) approuvé en Europe dans le traitement du purpura thrombotique thrombocytopénique (PTT) acquis de l'adulte Premier agent [...]
Bone Therapeutics SA : Information on the total number of voting rights and shares
03/09/2018
Regulated information Information on the total number of voting rights and shares Gosselies, Belgium, 3 September 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d'actions
03/09/2018
Information réglementée Information relative au nombre total de droits de vote et d'actions Gosselies, Belgique, le 3 septembre 2018, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de [...]
Fashion Development Materials is born, the new Bio-on business unit dedicated to bioplastic materials for fashion and the luxury sector
03/09/2018
PRESS RELEASE Fashion Development Materials is born, the new Bio-on business unit dedicated to bioplastic materials for fashion and the luxury sector. FDM, Fashion Development Materials , is added to the 5 business [...]
Biocartis Group NV: Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla(TM) Platform in China
03/09/2018
PRESS RELEASE : REGULATED INFORMATION-INSIDE INFORMATION 3 September 2018, 07:00 CST/ 01:00 CEST Biocartis and Wondfo Announce Joint Venture for Commercialization of Idylla(TM) Platform in China Mechelen, Belgium, and [...]
Sorrento Therapeutics to Present at FB Riley and HC Wainwright Sept 2018 Healthcare Conferences in NYC (NY)
02/09/2018
SAN DIEGO, Sept. 02, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will be participating in upcoming investment healthcare [...]
Innovate Biopharmaceuticals Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City September 4-6, 2018
01/09/2018
RALEIGH, N.C., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2018
CAMBRIDGE, Mass., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat [...]
Zenith Capital Closes $5.7 Million Private Placement
01/09/2018
This press release is not for dissemination in the United States or through US newswire services CALGARY, Alberta, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") today announced that [...]
Tetra Bio-Pharma Announces Record Date for Dividend-in-Kind of North Bud Farms Shares
31/08/2018
ORLEANS, Ontario, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discovery, [...]
Ortho Regenerative Technologies Inc. Announces CFO Change
31/08/2018
KIRKLAND, Quebec, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Ortho Regenerative Technologies Inc. ( CSE: ORTH ) (“ Ortho RTi ” or the “ Corporation” ) announces that Benedek (Ben) Simo has been appointed Interim Chief Financial [...]
Ascendis Pharma A/S Announces Upcoming Investor Presentations
31/08/2018
COPENHAGEN, Denmark, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]

Pages